Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASPER: Caspofungin for ICU Intra-abdominal Candidiasis
NCT03580733Phase 3Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Jan 2019
- Primary completion
- Oct 2024
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of caspofungin in Intra-abdominal candidiasis (IAC), sponsored by CHU Amiens-Picardie. Started Jan 2019; status: recruiting.
02
Drugs
caspofungin
03
Conditions
Intra-abdominal candidiasis (IAC)
Beyond the preview
Go deeper on NCT03580733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03580733.